MGO One Seven’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

MGO One Seven’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-152	Closed	-$1.23K	–	922
2023 Q1	$1.23K	Hold	152	–	–	﹤0.01%	863
2022 Q4	$1.8K	Hold	152	–	–	﹤0.01%	738
2022 Q3	$2	Hold	152	–	–	﹤0.01%	716
2022 Q2	$5K	Hold	152	–	–	﹤0.01%	644
2022 Q1	$6K	Hold	152	–	–	﹤0.01%	674
2021 Q4	$6K	Hold	152	–	–	﹤0.01%	665
2021 Q3	$11K	Hold	152	–	–	﹤0.01%	604
2021 Q2	$12K	Hold	152	–	–	﹤0.01%	590
2021 Q1	$9K	Hold	152	–	–	﹤0.01%	550
2020 Q4	$5K	Hold	152	–	–	﹤0.01%	494
2020 Q3	$8K	Hold	152	–	–	﹤0.01%	466
2020 Q2	$6K	Hold	152	–	–	﹤0.01%	453
2020 Q1	$3K	Hold	152	–	–	﹤0.01%	395
2019 Q4	$7K	Hold	152	–	–	﹤0.01%	441
2019 Q3	$7K	Hold	152	–	–	﹤0.01%	438
2019 Q2	$13K	Hold	152	–	–	﹤0.01%	405
2019 Q1	$22K	Hold	152	–	–	0.01%	416
2018 Q4	$23K	Hold	152	–	–	0.01%	879
2018 Q3	$37K	Buy	+152	New	+$36K	0.02%	355
2018 Q1	$1K	Hold	4	–	–	﹤0.01%	1744
2017 Q4	$1K	Buy	+4	New	+$1.32K	﹤0.01%	1726

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

MGO One Seven's DMK Position: Q2 2023 in Review

MGO One Seven sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 152 shares — an estimated $1.23K sold.

MGO One Seven first reported a position in DMK in Q4 2017 and held it in 21 quarters. The position peaked at $37K in Q3 2018. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

MGO One Seven reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
MGO One Seven sold 152 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1.23K.
MGO One Seven first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 21 quarters.
MGO One Seven's DMK Pharmaceuticals Corporation Common Stock position peaked at $37K in Q3 2018.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on MGO One Seven's 13F filing for Q2 2023, filed 11 Aug 2023.